Segundo, Mark S.
HRN: 23-34-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFUROXIME 750MG (VIAL)
01/23/2025
01/30/2025
IV
340mg
Q8h
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes